Ginkgo Non Current Liabilities Total vs Asset Turnover Analysis

DNA Stock

USD 10.83 0.63 6.18%

Ginkgo Bioworks financial indicator trend analysis is much more than just examining Ginkgo Bioworks Holdings latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ginkgo Bioworks Holdings is a good investment. Please check the relationship between Ginkgo Bioworks Non Current Liabilities Total and its Asset Turnover accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ginkgo Bioworks Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Non Current Liabilities Total vs Asset Turnover

Non Current Liabilities Total vs Asset Turnover Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ginkgo Bioworks Holdings Non Current Liabilities Total account and Asset Turnover. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Ginkgo Bioworks' Non Current Liabilities Total and Asset Turnover is 0.88. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Asset Turnover in the same time period over historical financial statements of Ginkgo Bioworks Holdings, assuming nothing else is changed. The correlation between historical values of Ginkgo Bioworks' Non Current Liabilities Total and Asset Turnover is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Ginkgo Bioworks Holdings are associated (or correlated) with its Asset Turnover. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Asset Turnover has no effect on the direction of Non Current Liabilities Total i.e., Ginkgo Bioworks' Non Current Liabilities Total and Asset Turnover go up and down completely randomly.

Correlation Coefficient

0.88

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Non Current Liabilities Total

Asset Turnover

The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.

Most indicators from Ginkgo Bioworks' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ginkgo Bioworks Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ginkgo Bioworks Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

The current year's Selling General Administrative is expected to grow to about 604 M, whereas Tax Provision is projected to grow to (12.5 M).

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	61.6M	71.6M	82.3M	86.4M
Interest Income	20.3M	57.2M	65.8M	69.1M

Depreciation And Amortization Interest Income

Ginkgo Bioworks fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets
Total Assets		0.85	0.95	0.94	1.0	0.86	0.95	0.89	-0.75	-0.88	0.69	0.96	0.91	0.97	0.87	0.96	0.82	0.92	-0.77	-0.69	0.98	0.89	0.69	0.91	0.98	0.96
Short Long Term Debt Total	0.85		0.77	0.86	0.81	0.48	0.83	0.99	-0.31	-0.87	0.63	0.67	0.99	0.94	0.86	0.67	0.41	0.95	-0.91	-0.9	0.94	0.84	0.94	0.89	0.93	0.66
Other Current Liab	0.95	0.77		0.96	0.94	0.91	0.99	0.8	-0.74	-0.92	0.65	0.94	0.83	0.92	0.89	0.94	0.76	0.92	-0.78	-0.69	0.92	0.92	0.57	0.95	0.94	0.93
Total Current Liabilities	0.94	0.86	0.96		0.92	0.8	0.98	0.9	-0.6	-0.96	0.81	0.87	0.92	0.95	0.94	0.87	0.68	0.97	-0.86	-0.8	0.94	0.93	0.75	0.98	0.97	0.86
Total Stockholder Equity	1.0	0.81	0.94	0.92		0.88	0.93	0.86	-0.79	-0.86	0.67	0.97	0.88	0.96	0.85	0.97	0.86	0.89	-0.73	-0.65	0.96	0.87	0.65	0.89	0.96	0.97
Other Liab	0.86	0.48	0.91	0.8	0.88		0.86	0.55	-0.93	-0.71	0.53	0.96	0.59	0.74	0.69	0.96	0.92	0.68	-0.49	-0.37	0.75	0.75	0.25	0.75	0.77	0.96
Net Tangible Assets	0.95	0.83	0.99	0.98	0.93	0.86		0.85	-0.68	-0.93	0.7	0.9	0.88	0.95	0.9	0.9	0.71	0.95	-0.81	-0.74	0.94	0.92	0.65	0.98	0.96	0.89
Property Plant And Equipment Net	0.89	0.99	0.8	0.9	0.86	0.55	0.85		-0.38	-0.89	0.7	0.73	1.0	0.96	0.88	0.73	0.5	0.96	-0.9	-0.88	0.96	0.86	0.94	0.91	0.95	0.72
Net Debt	-0.75	-0.31	-0.74	-0.6	-0.79	-0.93	-0.68	-0.38		0.48	-0.37	-0.9	-0.42	-0.59	-0.44	-0.9	-0.96	-0.48	0.21	0.09	-0.61	-0.51	-0.07	-0.53	-0.62	-0.9
Retained Earnings	-0.88	-0.87	-0.92	-0.96	-0.86	-0.71	-0.93	-0.89	0.48		-0.72	-0.79	-0.9	-0.92	-0.99	-0.79	-0.56	-0.96	0.95	0.91	-0.91	-0.98	-0.75	-0.97	-0.93	-0.78
Accounts Payable	0.69	0.63	0.65	0.81	0.67	0.53	0.7	0.7	-0.37	-0.72		0.6	0.71	0.68	0.75	0.6	0.57	0.7	-0.66	-0.62	0.67	0.67	0.7	0.71	0.72	0.61
Cash	0.96	0.67	0.94	0.87	0.97	0.96	0.9	0.73	-0.9	-0.79	0.6		0.76	0.88	0.77	1.0	0.92	0.8	-0.61	-0.51	0.89	0.82	0.46	0.82	0.89	1.0
Non Current Assets Total	0.91	0.99	0.83	0.92	0.88	0.59	0.88	1.0	-0.42	-0.9	0.71	0.76		0.98	0.9	0.76	0.53	0.97	-0.91	-0.88	0.97	0.88	0.92	0.92	0.97	0.75
Non Currrent Assets Other	0.97	0.94	0.92	0.95	0.96	0.74	0.95	0.96	-0.59	-0.92	0.68	0.88	0.98		0.91	0.88	0.67	0.98	-0.87	-0.81	1.0	0.92	0.81	0.95	1.0	0.87
Other Assets	0.87	0.86	0.89	0.94	0.85	0.69	0.9	0.88	-0.44	-0.99	0.75	0.77	0.9	0.91		0.77	0.56	0.93	-0.96	-0.92	0.9	0.99	0.77	0.94	0.92	0.77
Cash And Short Term Investments	0.96	0.67	0.94	0.87	0.97	0.96	0.9	0.73	-0.9	-0.79	0.6	1.0	0.76	0.88	0.77		0.92	0.8	-0.61	-0.51	0.89	0.82	0.46	0.82	0.89	1.0
Net Receivables	0.82	0.41	0.76	0.68	0.86	0.92	0.71	0.5	-0.96	-0.56	0.57	0.92	0.53	0.67	0.56	0.92		0.54	-0.33	-0.22	0.69	0.6	0.24	0.58	0.69	0.94
Good Will	0.92	0.95	0.92	0.97	0.89	0.68	0.95	0.96	-0.48	-0.96	0.7	0.8	0.97	0.98	0.93	0.8	0.54		-0.92	-0.88	0.97	0.93	0.84	0.99	0.98	0.79
Common Stock Shares Outstanding	-0.77	-0.91	-0.78	-0.86	-0.73	-0.49	-0.81	-0.9	0.21	0.95	-0.66	-0.61	-0.91	-0.87	-0.96	-0.61	-0.33	-0.92		0.99	-0.86	-0.94	-0.86	-0.9	-0.87	-0.6
Long Term Debt Total	-0.69	-0.9	-0.69	-0.8	-0.65	-0.37	-0.74	-0.88	0.09	0.91	-0.62	-0.51	-0.88	-0.81	-0.92	-0.51	-0.22	-0.88	0.99		-0.8	-0.89	-0.87	-0.85	-0.81	-0.49
Non Current Liabilities Total	0.98	0.94	0.92	0.94	0.96	0.75	0.94	0.96	-0.61	-0.91	0.67	0.89	0.97	1.0	0.9	0.89	0.69	0.97	-0.86	-0.8		0.91	0.8	0.94	1.0	0.88
Capital Surpluse	0.89	0.84	0.92	0.93	0.87	0.75	0.92	0.86	-0.51	-0.98	0.67	0.82	0.88	0.92	0.99	0.82	0.6	0.93	-0.94	-0.89	0.91		0.7	0.94	0.93	0.81
Other Current Assets	0.69	0.94	0.57	0.75	0.65	0.25	0.65	0.94	-0.07	-0.75	0.7	0.46	0.92	0.81	0.77	0.46	0.24	0.84	-0.86	-0.87	0.8	0.7		0.75	0.8	0.46
Other Stockholder Equity	0.91	0.89	0.95	0.98	0.89	0.75	0.98	0.91	-0.53	-0.97	0.71	0.82	0.92	0.95	0.94	0.82	0.58	0.99	-0.9	-0.85	0.94	0.94	0.75		0.96	0.81
Total Liab	0.98	0.93	0.94	0.97	0.96	0.77	0.96	0.95	-0.62	-0.93	0.72	0.89	0.97	1.0	0.92	0.89	0.69	0.98	-0.87	-0.81	1.0	0.93	0.8	0.96		0.89
Total Current Assets	0.96	0.66	0.93	0.86	0.97	0.96	0.89	0.72	-0.9	-0.78	0.61	1.0	0.75	0.87	0.77	1.0	0.94	0.79	-0.6	-0.49	0.88	0.81	0.46	0.81	0.89

Click cells to compare fundamentals

Ginkgo Bioworks Account Relationship Matchups

Ginkgo Bioworks fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	675.2M	2.1B	2.5B	1.7B	1.9B	1.7B
Short Long Term Debt Total	17.0M	23.0M	442.6M	241.8M	278.0M	163.1M
Other Current Liab	30.0M	92.6M	85.4M	86.1M	99.0M	73.0M
Total Current Liabilities	73.2M	134.8M	173.0M	163.9M	188.4M	128.7M
Total Stockholder Equity	461.4M	1.5B	1.7B	1.1B	1.3B	1.2B
Property Plant And Equipment Net	121.4M	145.8M	715.5M	397.2M	456.8M	317.5M
Net Debt	(363.8M)	(1.5B)	(873.2M)	(702.3M)	(632.1M)	(663.7M)
Retained Earnings	(467.9M)	(2.3B)	(4.4B)	(5.3B)	(4.8B)	(4.5B)
Accounts Payable	13.9M	8.2M	10.5M	9.3M	10.7M	9.7M
Cash	380.8M	1.6B	1.3B	944.1M	1.1B	1.0B
Non Current Assets Total	248.6M	347.9M	1.1B	663.6M	763.1M	557.7M
Non Currrent Assets Other	5.6M	44.0M	88.7M	55.8M	64.2M	44.8M
Cash And Short Term Investments	380.8M	1.6B	1.3B	944.1M	1.1B	1.0B
Net Receivables	21.9M	149.9M	82.5M	31.7M	36.5M	64.6M
Liabilities And Stockholders Equity	675.2M	2.1B	2.5B	1.7B	1.9B	1.7B
Non Current Liabilities Total	131.9M	368.9M	630.1M	404.3M	465.0M	371.9M
Inventory	2.7M	3.4M	4.4M	46K	52.9K	50.3K
Other Current Assets	21.1M	698K	47.5M	25.9M	29.8M	22.9M
Other Stockholder Equity	929.1M	3.8B	6.1B	6.4B	7.3B	4.0B
Total Liab	205.1M	503.6M	803.0M	568.2M	653.4M	500.6M
Total Current Assets	426.5M	1.7B	1.5B	1.0B	1.2B	1.1B
Short Term Debt	485K	747K	29.3M	19.9M	22.9M	24.1M
Intangible Assets	3.3M	21.6M	111.0M	82.7M	95.2M	49.0M
Common Stock	129K	161K	190K	199K	228.9K	166.8K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:

How To Invest In Ginkgo

Details

Is Ginkgo Stock a good investment?

Details

What is Ginkgo Bioworks' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ginkgo Bioworks Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(12.89)

Revenue Per Share

4.291

Quarterly Revenue Growth

0.606

Return On Assets

(0.21)

Return On Equity

(0.64)

The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ginkgo Non Current Liabilities Total vs Asset Turnover Analysis

Non Current Liabilities Total vs Asset Turnover

Non Current Liabilities Total vs Asset Turnover Correlation Analysis

Correlation Coefficient

Non Current Liabilities Total

Asset Turnover

Ginkgo Bioworks fundamental ratios Correlations

Ginkgo Bioworks Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ginkgo Bioworks fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Non Current Liabilities Total	+ 1.0	Non Currrent Assets Other
Total Liab	+ 1.0	Non Currrent Assets Other

Other Assets	- 0.99	Retained Earnings
Capital Surpluse	- 0.98	Retained Earnings
Other Stockholder Equity	- 0.97	Retained Earnings
Common Stock Shares Outstanding	- 0.96	Other Assets
Good Will	- 0.96	Retained Earnings
Net Receivables	- 0.96	Net Debt